Evidence map›Paper›PMID 24198373›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton.

Luke R Gabriel, Sijia Wu, Patrick Kearney, Karl D Bellvé, Clive Standley, Kevin E Fogarty, Haley E Melikian

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Substance Addiction Rehabilitation Drugs.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mutants of theInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Luke R GabrielBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, Neuroscience Graduate Program, Graduate School of Biomedical Sciences, and Program in Molecular Medicine, Biomedical Imaging Group, University of Massachusetts Medical School, Worcester, Massachusetts 01655.
Sijia Wu
Patrick Kearney
Karl D Bellvé
Clive Standley
Kevin E Fogarty
Haley E Melikian
University of Massachusetts Chan Medical School · USNeuropsychiatric Research Institute · USBioscience Research · US

Funding

Trafficking and Regulation of Monoamine TransportersR01DA015169 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELIKIAN, HALEY E · 2002 to 2017
$5.2M
Dopamine Transporter Cell Surface DynamicsR01DA035224 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELIKIAN, HALEY E · 2013 to 2022
$4.3M
NIDA NIH HHS DA035224NIDA NIH HHS DA15169NIDA NIH HHS R01 DA015169NIDA NIH HHS R01 DA035224
6 · The paper itself

Abstract

Dopaminergic signaling profoundly impacts rewarding behaviors, movement, and executive function. The presynaptic dopamine (DA) transporter (DAT) recaptures released DA, thereby limiting synaptic DA availability and maintaining dopaminergic tone. DAT constitutively internalizes and PKC activation rapidly accelerates DAT endocytosis, resulting in DAT surface loss. Longstanding evidence supports PKC-stimulated DAT trafficking in heterologous expression studies. However, PKC-stimulated DAT internalization is not readily observed in cultured dopaminergic neurons. Moreover, conflicting reports implicate both classic and nonclassic endocytic mechanisms mediating DAT trafficking. Prior DAT trafficking studies relied primarily upon chronic gene disruption and dominant-negative protein expression, or were performed in cell lines and cultured neurons, yielding results difficult to translate to adult dopaminergic neurons. Here, we use newly described dynamin inhibitors to test whether constitutive and PKC-stimulated DAT internalization are dynamin-dependent in adult dopaminergic neurons. Ex vivo biotinylation studies in mouse striatal slices demonstrate that acute PKC activation drives native DAT surface loss, and that surface DAT surprisingly partitions between endocytic-willing and endocytic-resistant populations. Acute dynamin inhibition reveals that constitutive DAT internalization is dynamin-independent, whereas PKC-stimulated DAT internalization is dynamin-dependent. Moreover, total internal reflection fluorescence microscopy experiments demonstrate that constitutive DAT internalization occurs equivalently from lipid raft and nonraft microdomains, whereas PKC-stimulated DAT internalization arises exclusively from lipid rafts. Finally, DAT endocytic recycling relies on a dynamin-dependent mechanism that acts in concert with the actin cytoskeleton. These studies are the first comprehensive investigation of native DAT trafficking in ex vivo adult neurons, and reveal that DAT surface dynamics are governed by complex multimodal mechanisms.

Indexed as

AnimalsCell Line, TumorCorpus StriatumCytoskeletonDopamine Plasma Membrane Transport ProteinsDopaminergic NeuronsDynaminsEndocytosisHumansMaleMiceProtein TransportDopamine Plasma Membrane Transport ProteinsDynamins

Identifiers

PMID24198373
PMCPMC3818556
OpenAlexW2063117763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.